Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376) |
---|
12/04/2001 | US6326394 Calixarene tubes as cation receptors |
12/04/2001 | US6326380 Thrombin receptor antagonists |
11/28/2001 | EP1157992A1 Dihydro-2,3-Benzodiazepine derivatives |
11/28/2001 | EP1157023A1 C-21 modified epothilones |
11/28/2001 | EP1156801A1 Compounds and methods |
11/28/2001 | EP0907647B1 Crown calix (4)arenes, method of preparation and use for selective extraction of caesium |
11/28/2001 | EP0770068B1 Conformationally rigid bicyclic and adamantane derivatives useful as alpha 2-adrenergic blocking agents |
11/28/2001 | CN1324355A Oxobenzofuranylide-dihydroindolone |
11/27/2001 | US6323206 Antiinflammatory agents and viricides for aids with cytokinesand chemokines |
11/22/2001 | WO2001005769A3 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
11/22/2001 | US20010044547 From l-mannonic-gamma-lactone intermediates; for prophylaxis of HIV/AIDS HIV |
11/21/2001 | CN1323287A Process for making aromatic aldehydes |
11/21/2001 | CN1323286A Process for making aromatic aldehydes using ionic liquids |
11/21/2001 | CN1075105C Polymerizable chiral compound and use thereof |
11/21/2001 | CN1074927C Active medical component of 'Duanshepiju' its extraction process and medicine containing the same |
11/20/2001 | US6320083 Reacting alkyl aromatic compound with carbon monoxide in presence of acidic ionic liquid to form alkyl aromatic aldehyde |
11/20/2001 | US6319946 Inhibitors of aspartyl protease |
11/20/2001 | US6319929 Suksdorfin analogs, compositions thereof, and methods for making and using thereof |
11/20/2001 | CA2024843C Synthesis of mannojirimycin derivatives |
11/20/2001 | CA2012507C Non-migrating 1-hydrocarbyloxy hindered amine compounds as polymer stabilizers |
11/15/2001 | WO2001085218A2 Acylated cyclodextrin guest inclusion complexes |
11/15/2001 | WO2001014339A3 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
11/15/2001 | WO2000044216A8 Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosis |
11/15/2001 | US20010041796 Taxol derivative; antitumor agents |
11/15/2001 | DE19954230A1 New, chemically and metabolically stable 16-halo or cyano-epothilone derivatives are cell division regulators useful e.g. for treating malignant tumors or chronic inflammatory disease |
11/14/2001 | CN1322205A Derivatives of isosorbid mononitrate, utilization as vasodilator agents with reduced tolerance |
11/13/2001 | US6316630 Treating epothilone to deoxygenate the epothilone, and thereby to provide the desoxyepothilone |
11/13/2001 | US6316491 Radicicol derivatives |
11/13/2001 | US6316486 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides |
11/13/2001 | US6315928 For ophthalmic lenses |
11/08/2001 | WO2001083500A1 13-substituted milbemycin derivatives, their preparation and their use against insects and other pests |
11/08/2001 | WO2001083488A1 Improved synthesis of anhydroglycitol esters of improved colour |
11/08/2001 | WO2001083476A1 Chromenylmethyl pyrimidinediamines as antibacterial agents |
11/08/2001 | CA2407611A1 13-substituted milbemycin derivatives, their preparation and their use against insects and other pests |
11/08/2001 | CA2405614A1 Chromenylmethyl pyrimidinediamines as antibacterial agents |
11/07/2001 | EP1151295A1 Methods of identifying therapeutically effective antineoplastic agents with cultured cells having intact cell membranes and corresponding products |
11/07/2001 | EP1150984A1 Artemisinin analogs having antimalarial, antiproliferative, and antitumor activities and chemoselective methods of making the same |
11/07/2001 | EP1150980A2 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use |
11/07/2001 | CN1074414C indolylalkyl derivs. of benzodioxanmethylamine as 5-HT1A receptor ligands |
11/06/2001 | US6313326 Compounds and their application as well as a method of producing liquid crystalline polymers therefrom |
11/06/2001 | US6313320 Process for the preparation of calanolide precursors |
11/06/2001 | US6313204 Heating and melting a resin formulation comprising polyolefin resin, nucleating agent containing diacetal compound to give molten resin in which nucleating agent is uniformly dissolved; cooling |
11/06/2001 | US6313160 Substituted heterocyclic compounds, method for preparing and compositions containing same |
11/01/2001 | WO2001081351A1 Fluorescent compounds |
11/01/2001 | WO2001081342A2 Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use |
11/01/2001 | WO2001081341A2 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations |
11/01/2001 | WO2001081338A1 Substituted sulfonylaminopyrimidines |
11/01/2001 | WO2001030736A3 Aromatic di-keto derivatives as glucose-6-phosphate translocase inhibitors |
11/01/2001 | WO2000039276A9 Microbial transformation method for the preparation of an epothilone |
11/01/2001 | US20010036652 Diels-Alder process; antitumor agents |
11/01/2001 | CA2407641A1 Fluorescent compounds |
10/31/2001 | EP1043988A4 C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumour activities |
10/31/2001 | CN1073996C Crystalline form of dihydro-2,3-benzodiazepine derivative |
10/31/2001 | CN1073995C Physical form of dihydro-2,3-benzodiazepine derivative |
10/31/2001 | CN1073825C Food composition containing balancing agent for omega'-6-and'omega'-3 unsaturated fatty acids |
10/30/2001 | US6309881 Aldehyde and ketone reactants are contacted with antibody molecules or molecules containing antibody combining site portions that catalyze an aldol addition reaction |
10/30/2001 | US6309687 Anti-first-pass effect compounds |
10/30/2001 | CA2029863C Compositions and methods for treating viral infections |
10/25/2001 | WO2001079247A1 Novel discalamide compounds and their use as anti-proliferative agents |
10/25/2001 | WO2001079246A2 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections |
10/25/2001 | WO2001079203A1 Herbicidal 3-heterocyclic substituted benzisothiazole and benzisoxazole compounds |
10/25/2001 | WO2000056737A9 Calanolides for inhibiting btk |
10/25/2001 | WO2000054768A9 Anti-first-pass effect compounds |
10/25/2001 | US20010034452 Epothilons C and D, preparation and compositions |
10/25/2001 | US20010033944 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied |
10/25/2001 | DE10020899A1 New 9-oxa-epothilone derivatives, are phase-specific cell division regulators useful for treating malignant tumors, angiogenesis or inflammatory disease |
10/25/2001 | DE10020517A1 New 13-halo or cyano-epothilone derivatives, are phase-specific cell division regulators useful for treating malignant tumors, angiogenesis or inflammatory disease |
10/25/2001 | CA2408396A1 Herbicidal 3-heterocyclic substituted benzisothiazole and benzisoxazole compounds |
10/25/2001 | CA2404639A1 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections |
10/24/2001 | CN1073562C Method for extracting material containing raw anthocyanidin from ginkgo leaf by supercritical carbon dioxide |
10/23/2001 | US6307068 Artemisinin derivatives, method for the preparation thereof and pharmaceutical compositions containing the same |
10/23/2001 | US6307057 Catalyze enantioselective reactions, e.g., diels-alder reactions |
10/23/2001 | US6306899 Viricides |
10/23/2001 | US6306897 Calanolides for inhibiting BTK |
10/23/2001 | US6306896 Pharmaceutically active composition containing artemisinine and/or derivative of artemisinine |
10/23/2001 | US6306587 Template-directed photoligation |
10/23/2001 | CA2037411C Milbemycin ether derivatives |
10/18/2001 | WO2001078162A2 Oligomeric and polymeric oled materials produced via arylation of quinones |
10/17/2001 | EP1144417A1 4'-substituted-4',5'-dihydropsoralens and therapeutical uses thereof |
10/17/2001 | EP1144416A1 Heterocyclically anellated indenochromene derivatives |
10/17/2001 | EP1144390A2 Kinase inhibitors |
10/17/2001 | EP1143991A2 Inhibitors of h+k+ -atpase |
10/17/2001 | CN1317937A Compsn. containing natural phenolic compound for preventing or treating elevated blood liquid level-related diseases |
10/16/2001 | US6303827 Process for making aromatic aldehydes |
10/16/2001 | US6303789 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors |
10/16/2001 | US6303342 Recombinant methods and materials for producing epothilones C and D |
10/11/2001 | WO2001074798A1 Reworkable composition of oxirane(s) or thiirane(s)-containing resin and curing agent |
10/11/2001 | WO2001074741A2 Catalytic asymmetric desymmetrization of meso compounds |
10/11/2001 | US20010029303 Total synthesis of antitumor acylfulvenes |
10/11/2001 | US20010029265 Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
10/11/2001 | DE10015836A1 New epothilone derivatives used for treating e.g. malignant melanoma, breast carcinoma, psoriasis, multiple sclerosis and arthritis |
10/11/2001 | CA2405535A1 Catalytic asymmetric desymmetrization of meso compounds |
10/11/2001 | CA2403595A1 Reworkable composition of oxirane(s) or thiirane(s)-containing resin and curing agent |
10/10/2001 | EP1140944A1 Epothilone derivatives and their use as antitumor agents |
10/10/2001 | EP1140928A2 Microbial transformation method for the preparation of an epothilone |
10/10/2001 | EP1140888A1 Optical molecular sensors for cytochrome p450 activity |
10/10/2001 | EP1140884A1 Process for production of an oxetane |
10/10/2001 | EP1140811A1 Novel herbicides |
10/10/2001 | EP1140733A1 Process and products of purification of anhydrosugar alcohols |
10/10/2001 | EP1140069A1 COMPOUNDS WHICH AFFECT mRNA STABILITY AND USES THEREFOR |